Thus, it is tempting to speculate that TRPA1 could provide a mechanistic framework for improved treatment of prodromal pain and peripheral neuropathy in Parkinson’s disease, which is currently limited owing, in part, to a lack of understanding of its underlying mechanisms. This evidence concerns the gene TRPA1 and Parkinson disease.